mortality/aging
• earliest deaths at 19 and 29 weeks of age
• survival rate at 1 year is 61.1% in males and 46.2% in females
|
immune system
• anomalous differentiation of T cells, with anomalous expression of surface antigens
|
• five times higher than in controls
(J:81770)
|
• two times higher than in controls
(J:81770)
|
• palpable by 3 months of age
|
• spleens larger in females than males
• spleen weights increase up to 6 months of age and remain at a plateau thereafter
|
• enlargement of the superficial lymph nodes starts at about 2.5 months of age, with cervical preceding inguinal lymph nodes
(J:24805)
• superficial lymph nodes are more than 5 and 15 times heavier than controls at 3 and 5 months of age, respectively
(J:24805)
• mesenteric lymph nodes are normal in size
(J:24805)
|
• lymphocyte infiltration in liver, lungs, spleen, and kidneys
(J:24805)
|
• elevated levels of autoantibodies to nuclear antigens including anti-DNA
|
hematopoietic system
• palpable by 3 months of age
|
• spleens larger in females than males
• spleen weights increase up to 6 months of age and remain at a plateau thereafter
|
• anomalous differentiation of T cells, with anomalous expression of surface antigens
|
• five times higher than in controls
(J:81770)
|
• two times higher than in controls
(J:81770)
|
growth/size/body
• palpable by 3 months of age
|
• spleens larger in females than males
• spleen weights increase up to 6 months of age and remain at a plateau thereafter
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
autoimmune lymphoproliferative syndrome | DOID:6688 |
OMIM:601859 |
J:24805 , J:81770 |